Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
CCData: April transaction volume was $6.58 trillion, the first decline in seven months

CCData: April transaction volume was $6.58 trillion, the first decline in seven months

Bitget2024/05/09 07:25

Golden Finance reported that cryptocurrency trading volume cooled in April, falling for the first time in seven months, as escalating geopolitical tensions and slowing inflows of funds from U.S.-listed spot ETFs put pressure on the digital asset market. According to a report by CCData, a London-based digital asset data provider, cumulative trading volume in the spot and derivatives markets fell 43.8% to $6.58 trillion, a sharp drop from the all-time high of $9.12 trillion set in March.

Derivatives once again lost favor with investors as activity in futures and options markets fell 47.6% to $4.57 trillion. Meanwhile, spot market volume fell 32.6% to $2.01 trillion. CCData said in a report that the decline was due to unexpected macroeconomic data, escalating geopolitical crises in the Middle East, and negative net flows of U.S. spot Bitcoin ETFs, which caused major crypto assets to give up their gains in March.

1
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A historic breakthrough in pancreatic cancer treatment! FDA approves RevMed's targeted new drug, with sales expected to exceed $9 billion by 2032.

The oral new drug daraxonrasib from RevMed has been officially approved by the FDA for market launch, with an annual list price exceeding $475,000. It is the first targeted drug aimed at the key molecular pathogenic mechanism of pancreatic cancer. Clinical trials show that the median survival time for patients almost doubled, increasing from 6.7 months to 13.2 months. According to data from the American Cancer Society, over 52,000 people are expected to die from pancreatic cancer this year. Wall Street predicts that sales could surpass $9 billions by 2032.

华尔街见闻2026/08/26 20:06